BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26657027)

  • 1. Infectious dengue vesicles derived from CD61+ cells in acute patient plasma exhibited a diaphanous appearance.
    Hsu AY; Wu SR; Tsai JJ; Chen PL; Chen YP; Chen TY; Lo YC; Ho TC; Lee M; Chen MT; Chiu YC; Perng GC
    Sci Rep; 2015 Dec; 5():17990. PubMed ID: 26657027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of bone marrow cells by dengue virus in vivo.
    Noisakran S; Onlamoon N; Hsiao HM; Clark KB; Villinger F; Ansari AA; Perng GC
    Exp Hematol; 2012 Mar; 40(3):250-259.e4. PubMed ID: 22193689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow.
    Clark KB; Noisakran S; Onlamoon N; Hsiao HM; Roback J; Villinger F; Ansari AA; Perng GC
    PLoS One; 2012; 7(12):e52902. PubMed ID: 23300812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD61+ cells in thrombocytopenia of dengue patients.
    Noisakran S; Onlamoon N; Pattanapanyasat K; Hsiao HM; Songprakhon P; Angkasekwinai N; Chokephaibulkit K; Villinger F; Ansari AA; Perng GC
    Int J Hematol; 2012 Nov; 96(5):600-10. PubMed ID: 22987294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing dengue virus maturation using a stable furin over-expressing cell line.
    Mukherjee S; Sirohi D; Dowd KA; Chen Z; Diamond MS; Kuhn RJ; Pierson TC
    Virology; 2016 Oct; 497():33-40. PubMed ID: 27420797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope.
    Metz SW; Thomas A; White L; Stoops M; Corten M; Hannemann H; de Silva AM
    Virol J; 2018 Apr; 15(1):60. PubMed ID: 29609659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
    Thomas A; Thiono DJ; Kudlacek ST; Forsberg J; Premkumar L; Tian S; Kuhlman B; de Silva AM; Metz SW
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants in Nonstructural Protein 4A of Dengue Virus Required for RNA Replication and Replication Organelle Biogenesis.
    Cortese M; Mulder K; Chatel-Chaix L; Scaturro P; Cerikan B; Plaszczyca A; Haselmann U; Bartenschlager M; Neufeldt CJ; Bartenschlager R
    J Virol; 2021 Oct; 95(21):e0131021. PubMed ID: 34379504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies.
    Raut R; Corbett KS; Tennekoon RN; Premawansa S; Wijewickrama A; Premawansa G; Mieczkowski P; Rückert C; Ebel GD; De Silva AD; de Silva AM
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):227-232. PubMed ID: 30518559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
    Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
    J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.
    de Alwis R; Smith SA; Olivarez NP; Messer WB; Huynh JP; Wahala WM; White LJ; Diamond MS; Baric RS; Crowe JE; de Silva AM
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7439-44. PubMed ID: 22499787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies.
    Young E; Carnahan RH; Andrade DV; Kose N; Nargi RS; Fritch EJ; Munt JE; Doyle MP; White L; Baric TJ; Stoops M; DeSilva A; Tse LV; Martinez DR; Zhu D; Metz S; Wong MP; Espinosa DA; Montoya M; Biering SB; Sukulpolvi-Petty S; Kuan G; Balmaseda A; Diamond MS; Harris E; Crowe JE; Baric RS
    Cell Host Microbe; 2020 May; 27(5):710-724.e7. PubMed ID: 32407709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism and significance of cell type-dependent neutralization of flaviviruses.
    Mukherjee S; Dowd KA; Manhart CJ; Ledgerwood JE; Durbin AP; Whitehead SS; Pierson TC
    J Virol; 2014 Jul; 88(13):7210-20. PubMed ID: 24741083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
    Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
    PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue virus capsid protein usurps lipid droplets for viral particle formation.
    Samsa MM; Mondotte JA; Iglesias NG; Assunção-Miranda I; Barbosa-Lima G; Da Poian AT; Bozza PT; Gamarnik AV
    PLoS Pathog; 2009 Oct; 5(10):e1000632. PubMed ID: 19851456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells.
    Clark KB; Hsiao HM; Bassit L; Crowe JE; Schinazi RF; Perng GC; Villinger F
    Virology; 2016 Jun; 493():162-72. PubMed ID: 27058763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.
    Briggs CM; Smith KM; Piper A; Huitt E; Spears CJ; Quiles M; Ribeiro M; Thomas ME; Brown DT; Hernandez R
    J Virol; 2014 Jun; 88(12):6729-42. PubMed ID: 24696467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue virus induces interferon-β by activating RNA sensing pathways in megakaryocytes.
    Arya RP; Lahon A; Patel AK
    Immunol Lett; 2021 Aug; 236():31-36. PubMed ID: 34111476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4.
    Barban V; Mantel N; De Montfort A; Pagnon A; Pradezynski F; Lang J; Boudet F
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.